Prime Minister Manmohan Singh has directed Indian negotiators not to take Intellectual Property Rights (IPR) obligation, particularly in pharmaceuticals, beyond domestic laws or as mandated in a World Trade Organisation pact, while entering into a Foreign Trade Agreement (FTA) with European Union (EU).
While reviewing the status of the negotiations, it was observed that certain concerns have been raised about the Indian stand on issues relating to IPR, especially in the context of the pharma products. The EU has been demanding that India should enforce a stricter IPR regime than what has been mandated in its domestic laws and the WTO agreement on TRIPS. EU is India’s largest trading partner with commercial engagement of $74 billion in 2009-10.
TERC, headed by the Prime Minister, also approved launch of negotiations for an FTA with Australia. It was apprised to TERC that while there has been a substantial growth in bilateral merchandise trade with Australia, ‘tariffs and non-tariff barriers continue to raise the cost of imports, imposing implicit taxes on businesses and consumers alike’. It was felt that a comprehensive FTA with Australia would benefit both the countries.
India’s bilateral trade with Australia stood at around $14 billion in the financial year 2009-10. The committee which comprises, among others, finance minister Pranab Mukherjee, commerce and industry minister Anand Sharma and external affairs minister S M Krishna, also considered proposal for establishing a joint study group to examine feasibility of comprehensive FTA/Preferential Trade Agreement with the Common Market of Eastern and Southern Africa.
India has already implemented free trade pacts with South Korea and ASEAN and has signed comprehensive pacts with Japan and Malaysia. The duties and barriers on trade are significantly removed or eliminated under FTAs.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
